←Back to Expert Scholars
Translational Medicine / 转化医学CAR-T Manufacturing, Industrial Scale
Adrian Bot
MD, PhD
🏢Capstan Therapeutics🌐USA
Chief Scientific Officer
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Adrian Bot previously led Kite Pharma R&D during axicabtagene development and now drives in vivo CAR-T at Capstan. His work bridges industrial CAR-T manufacturing and next-generation RNA-delivered CAR approaches. He has contributed to multiple FDA approvals.
Share:
🧪Research Fields 研究领域
CAR-T manufacturing
axi-cel
lisocabtagene
in vivo CAR
industrial cell therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Adrian Bot 的研究动态
Follow Adrian Bot's research updates
留下邮箱，当我们发布与 Adrian Bot（Capstan Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment